Trademark: 97345459
Word
DURATOCIN
Status Date
Monday, June 17, 2024
Filing Date
Monday, April 4, 2022
Published for Opposition
Tuesday, May 30, 2023
5 Pharmaceutical products and preparations for use in the treatment of reproductive and maternal health conditions, diseases and disorders
Jun 28, 2022
Non-Final Action E-Mailed
Apr 7, 2022
New Application Entered
Apr 8, 2022
New Application Office Supplied Data Entered
Jun 26, 2022
Assigned To Examiner
Jun 28, 2022
Non-Final Action Written
Jun 28, 2022
Notification Of Non-Final Action E-Mailed
Dec 21, 2022
Teas Response To Office Action Received
Dec 21, 2022
Correspondence Received In Law Office
Dec 22, 2022
Teas/Email Correspondence Entered
Jan 24, 2023
Non-Final Action Written
Jan 24, 2023
Non-Final Action E-Mailed
Jan 24, 2023
Notification Of Non-Final Action E-Mailed
Apr 17, 2023
Teas Response To Office Action Received
Apr 17, 2023
Correspondence Received In Law Office
Apr 17, 2023
Teas/Email Correspondence Entered
Apr 25, 2023
Approved For Pub - Principal Register
May 10, 2023
Notification Of Notice Of Publication E-Mailed
May 30, 2023
Published For Opposition
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 25, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2023
Sou Teas Extension Received
Nov 29, 2023
Sou Extension 1 Filed
Nov 29, 2023
Sou Extension 1 Granted
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 17, 2024
Sou Teas Extension Received
Jun 17, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 17, 2024
Sou Extension 2 Granted
Jun 17, 2024
Sou Extension 2 Filed
Jul 1, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 1, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 1, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 1, 2024
Teas Change Of Correspondence Received
Jul 1, 2024
Teas Change Of Domestic Representatives Address
Trademark Alertz updated from USPTO on 2030-01-24
